Wed, November 27, 2024
Tue, November 26, 2024
Mon, November 25, 2024
Sun, November 24, 2024
Wed, November 13, 2024
Tue, November 12, 2024
Tue, October 8, 2024
Mon, October 7, 2024
Fri, October 4, 2024

CytoDyn (OTCMKTS:CYDY) Holds 2024 Annual Meeting of Stockholders


//stocks-investing.news-articles.net/content/202 .. y-holds-2024-annual-meeting-of-stockholders.html
Published in Stocks and Investing on Sunday, November 24th 2024 at 14:56 GMT by Thomas Matters   Print publication without navigation

  • CytoDyn Inc. recently conducted its 2024 Annual Meeting of Stockholders on November 22, 2024. In a Form 8-K filing issued on the same day, the final voting results were disclosed, showing several key outcomes from the meeting.

The article from ETF Daily News discusses CytoDyn Inc.'s (OTC: CYDY) 2024 Annual Meeting of Stockholders, which took place on November 24, 2024. The meeting covered several key points including the company's progress on its lead drug candidate, leronlimab, for treating various diseases such as HIV, cancer, and autoimmune disorders. Shareholders voted on several proposals, including the election of directors, the ratification of the company's independent registered public accounting firm, and an advisory vote on executive compensation. CEO Dr. Nader Pourhassan provided updates on clinical trials, regulatory milestones, and strategic partnerships aimed at advancing leronlimab through the FDA approval process. The meeting also highlighted the company's financial health, ongoing research, and future plans to expand its therapeutic pipeline.

Read the Full ETF Daily News Article at [ https://www.etfdailynews.com/2024/11/24/cytodyn-otcmktscydy-holds-2024-annual-meeting-of-stockholders/ ]

Publication Contributing Sources